219 related articles for article (PubMed ID: 23242072)
1. Pathogenesis and malignant transformation of adenomyosis (review).
Koike N; Tsunemi T; Uekuri C; Akasaka J; Ito F; Shigemitsu A; Kobayashi H
Oncol Rep; 2013 Mar; 29(3):861-7. PubMed ID: 23242072
[TBL] [Abstract][Full Text] [Related]
2. Malignant changes in adenomyosis in patients with endometrial adenocarcinoma: A case series.
Mao X; Zheng W; Mao W
Medicine (Baltimore); 2017 Oct; 96(43):e8336. PubMed ID: 29069006
[TBL] [Abstract][Full Text] [Related]
3. Adenomyosis as a Risk Factor for Myometrial or Endometrial Neoplasms-Review.
Szubert M; Kozirog E; Wilczynski J
Int J Environ Res Public Health; 2022 Feb; 19(4):. PubMed ID: 35206475
[TBL] [Abstract][Full Text] [Related]
4. Endometrioid adenocarcinoma arising from adenomyosis: a case report.
Szegedi S; Koppan M; Varga T; Kovacs K; Tinneberg HR; Bodis J
Eur J Gynaecol Oncol; 2016; 37(6):858-860. PubMed ID: 29943936
[TBL] [Abstract][Full Text] [Related]
5. Small primary adenocarcinoma in adenomyosis with nodal metastasis: a case report.
Puppa G; Shozu M; Perin T; Nomura K; Gloghini A; Campagnutta E; Canzonieri V
BMC Cancer; 2007 Jun; 7():103. PubMed ID: 17584489
[TBL] [Abstract][Full Text] [Related]
6. Adenomyosis and Endometrial Cancer: Literature Review.
Habiba M; Pluchino N; Petignat P; Bianchi P; Brosens IA; Benagiano G
Gynecol Obstet Invest; 2018; 83(4):313-328. PubMed ID: 29874641
[TBL] [Abstract][Full Text] [Related]
7. Endometrial adenocarcinoma involving adenomyosis without true myometrial invasion is characterized by frequent preceding estrogen therapy, low histologic grades, and excellent prognosis.
Mittal KR; Barwick KW
Gynecol Oncol; 1993 May; 49(2):197-201. PubMed ID: 8504988
[TBL] [Abstract][Full Text] [Related]
8. The role of CD10 staining in distinguishing invasive endometrial adenocarcinoma from adenocarcinoma involving adenomyosis.
Nascimento AF; Hirsch MS; Cviko A; Quade BJ; Nucci MR
Mod Pathol; 2003 Jan; 16(1):22-7. PubMed ID: 12527709
[TBL] [Abstract][Full Text] [Related]
9. Adenomyosis is associated with myometrial invasion by FIGO 1 endometrial adenocarcinoma.
Ismiil ND; Rasty G; Ghorab Z; Nofech-Mozes S; Bernardini M; Thomas G; Ackerman I; Covens A; Khalifa MA
Int J Gynecol Pathol; 2007 Jul; 26(3):278-83. PubMed ID: 17581412
[TBL] [Abstract][Full Text] [Related]
10. Adenomyosis involved by endometrial adenocarcinoma is a significant risk factor for deep myometrial invasion.
Ismiil N; Rasty G; Ghorab Z; Nofech-Mozes S; Bernardini M; Ackerman I; Thomas G; Covens A; Khalifa MA
Ann Diagn Pathol; 2007 Aug; 11(4):252-7. PubMed ID: 17630108
[TBL] [Abstract][Full Text] [Related]
11. Very early stage adenocarcinoma arising from adenomyosis in the uterus.
Hsu MI; Chou SY; Lin SE; Liang SJ; Chiu HC; Hsu CS
Taiwan J Obstet Gynecol; 2006 Dec; 45(4):346-9. PubMed ID: 17175497
[TBL] [Abstract][Full Text] [Related]
12. CD10 imunostaining does not distinguish endometrial carcinoma invading myometrium from carcinoma involving adenomyosis.
Srodon M; Klein WM; Kurman RJ
Am J Surg Pathol; 2003 Jun; 27(6):786-9. PubMed ID: 12766582
[TBL] [Abstract][Full Text] [Related]
13. Infiltrating adenomyosis of the cervix with features of a low-grade stromal sarcoma: a case report and a literature review.
Chen X; Hamele-Bena D; Galic VL; Liu-Jarin X; Ko YC; Herzog T; Wright JD; Wright TC
Int J Gynecol Pathol; 2014 May; 33(3):253-7. PubMed ID: 24681735
[TBL] [Abstract][Full Text] [Related]
14. Molecular Characteristics of the Endometrium in Uterine Adenomyosis and Its Biochemical Microenvironment.
Yen CF; Huang SJ; Lee CL; Wang HS; Liao SK
Reprod Sci; 2017 Oct; 24(10):1346-1361. PubMed ID: 28183227
[TBL] [Abstract][Full Text] [Related]
15. Malignant transformation of adenomyosis: literature review and meta-analysis.
Yuan H; Zhang S
Arch Gynecol Obstet; 2019 Jan; 299(1):47-53. PubMed ID: 30519753
[TBL] [Abstract][Full Text] [Related]
16. Rare case of endometrioid adenocarcinoma arising from cystic adenomyosis.
Mori M; Furusawa A; Kino N; Uno M; Ozaki Y; Yasugi T
J Obstet Gynaecol Res; 2015 Feb; 41(2):324-8. PubMed ID: 25331723
[TBL] [Abstract][Full Text] [Related]
17. CD10 immunostaining distinguishes atypical polypoid adenomyofibroma (atypical polypoid adenomyoma) from endometrial carcinoma invading the myometrium.
Ohishi Y; Kaku T; Kobayashi H; Aishima S; Umekita Y; Wake N; Tsuneyoshi M
Hum Pathol; 2008 Oct; 39(10):1446-53. PubMed ID: 18619643
[TBL] [Abstract][Full Text] [Related]
18. Adenomyosis As a Confounder to Accurate Endometrial Cancer Staging.
Khalifa MA; Atri M; Klein ME; Ghatak S; Murugan P
Semin Ultrasound CT MR; 2019 Aug; 40(4):358-363. PubMed ID: 31375175
[TBL] [Abstract][Full Text] [Related]
19. The expression and functionality of stromal caveolin 1 in human adenomyosis.
Zhao L; Zhou S; Zou L; Zhao X
Hum Reprod; 2013 May; 28(5):1324-38. PubMed ID: 23442759
[TBL] [Abstract][Full Text] [Related]
20. Tumor Characteristics and Survival Outcome of Endometrial Cancer Arising in Adenomyosis: An Exploratory Analysis.
Matsuo K; Moeini A; Machida H; Scannell CA; Casabar JK; Kakuda M; Adachi S; Garcia-Sayre J; Ueda Y; Roman LD
Ann Surg Oncol; 2016 Mar; 23(3):959-67. PubMed ID: 26542589
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
